SERMs (Merck & Co)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameSERMs (Merck & Co)
Drug Alias Name2-phenylspiroindenes (Merck & Co)selective estrogen receptor modulators (Merck & Co)estrogen receptor modulators (Karo Bio/Merck & Co)IDBBCP-171584
ClassificationSmall molecules
Mechanisms of ActionEstrogen receptor beta modulatorsEstrogen receptor alpha modulatorsBone modulators
TargetsEstrogen receptor betaEstrogen receptor alpha
Therapy Area/IndicationsOestrogen deficiency symptomsOsteoporosisBreast Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSweden
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKaro Pharma Ab
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKaro Pharma AbMerck & Co Inc
Active IndicationsN/A
Inactive IndicationsOestrogen deficiency symptomsOsteoporosisBreast Neoplasms +[4] 

Other Information

ATC CodeN/A
Related LinksN/A